Skip to main content
Premium Trial:

Request an Annual Quote

Amersham Biosciences Sells 21 MegaBACE 4000s to JGI

NEW YORK, Oct. 23 - Amersham Biosciences said on Tuesday that the US Department of Energy's Joint Genome Institute has bought 21 of its MegaBACE 4000 DNA analysis system.

The new ultra high-throughput systems are intended to augment JGI's current sequencing operations, which are built on the MegaBACE platform, according to the company. Installation has already begun, the company added.

Amersham Biosciences, a unit of UK-based Amersham, would not say how much the JGI paid for the 21 modules. Each unit has a list price of $450,000, according to an Amersham Biosciences spokeswoman.

According to the Piscataway, NJ-based company, the MegaBACE 4000, which will be unveiled at the 13th annual Genome Sequencing and Analysis Conference in San Diego this week, builds upon the MegaBACE 100+00 system. The new model, which uses the Sequence Analyser v3.0 software kit, “incorporates improvements in optics, data collection, and overall data management,” the company said.

Last week, Amersham changed the names of both of its businesses : Amersham Biosciences, Amersham’s life-sciences unit, was formerly known as Amersham Pharmacia Biotech, and Amersham Health, the group’s medical diagnostics and therapy business, was formerly called Nycomed Amersham Imaging.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.